Differences in proliferation of the hematopoietic cell line TF-1 and cytokine production by peripheral blood leukocytes induced by 2 naturally occurring forms of human IL-3
A. Schweiger et al., Differences in proliferation of the hematopoietic cell line TF-1 and cytokine production by peripheral blood leukocytes induced by 2 naturally occurring forms of human IL-3, J ALLERG CL, 107(3), 2001, pp. 505-510
Background: A naturally occurring polymorphism in the coding region of the
human IL3 gene leads to a change in amino acid residue 8 from proline to se
rine.
Objective: We sought to determine whether the 2 different forms of IL-3 var
ied in function. These different forms are available as recombinant protein
s (recombinant human IL-3/proline 8 [rhIL-3/P8] and recombinant human IL-3/
serine 8 [rhIL-3/S8]).
Methods: The erythroleukemic cell line TF-1 was incubated with varying conc
entrations of rhIL-3/P8 or rhIL-3/S8 to determine the capacity of each type
of IL-3 to induce proliferation. Human leukocytes were primed with rhIL-3/
P8 or rhIL-3/S8 for up to 24 hours and then stimulated with anti-IgE and as
sessed for leukotrienes (LTs), IL-4, and TNF-alpha.
Results: Proliferation of TF-1 cells was induced by both forms of IL-3 at 4
8 and 72 hours but to a greater degree by rhIL-3/P8, In contrast, the mean
fold increase over control values of LT and IL-4 production was higher afte
r priming the cells with rhIL-3/S8 versus rhIL-3/P8. Additionally, TNF-alph
a production was greater (and reached significance only) for rhIL-3/S8. Thi
s activity was independent of IgE and thus directly stimulated by IL-3. Stu
dies with basophil-enriched and basophil-depleted cell preparations reveale
d that LT production was evident only from the former and TNF-alpha only fr
om the latter.
Conclusion: We conclude that the 2 naturally occurring forms of human IL-3
have similar spectra of activities on cells with IL-3 receptors, but the 2
forms have reversed relative efficacies for promoting proliferation (rhIL-3
/P8 > rhIL-3/S8) compared with priming or inducing mediator secretion (rhIL
-3/S8 > rhIL-3/P8).